Skip to content

Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens

Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens: A Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07439835
Acronym
IOL-VAC
Enrollment
62
Registered
2026-02-27
Start date
2024-04-01
Completion date
2025-12-15
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IOL, Cataract, Presbyopia

Keywords

pseudophakic presbyopic correction, enhanced monofocal intraocular lens, defocus curves, visual curves, digital optotype

Brief summary

The primary objective of this study is to evaluate postoperative visual acuity curves in pseudophakic patients following unilateral or bilateral implantation of the enhanced monofocal TECNIS Eyhance IOL, using the DDARTVC.

Detailed description

The present study aims to identify the exact points of the visual acuity curve, in which the enhanced monofocal TECNIS Eyhance IOL exhibit the optimal visual performance. Specifically, the study takes into account that the validated digital acuity chart DDARTVC assesses visual acuity under real-life conditions at nine discrete distances (25, 28, 33, 40, 50, 60, 100, 200, and 300 cm), rather than through simulated defocus values. Moreover, spline curve fitting was applied to the measured data points to generate continuous visual acuity curves, enabling estimation of visual performance across the full range of distances, rather than only at the predefined measurement points.

Interventions

PROCEDUREPhacoemulsification with enhanced monofocal IOLs

Uneventful pseudophakic presbyopic correction with the enhanced monofocal IOL TECNIS® Eyhance ICB00 (Johnson \& Johnson Vision, USA)

Sponsors

Democritus University of Thrace
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* age between 45 to 75 years

Exclusion criteria

* astigmatism \>1.00 diopters * glaucoma * former incisional eye surgery * corneal or fundus disease * diabetes mellitus * autoimmune diseases * neurological or psychiatric diseases * posterior capsule rupture or lens misalignment * postoperative uncorrected distance visual acuity \< 8/10.

Design outcomes

Primary

MeasureTime frameDescription
Uncorrected Visual Acuity assessment3 months postoperativelyVisual acuity assessment in 9 discrete distances (25, 28, 33, 40, 50, 60, 100, 200, and 300 cm) using the DDARTVC chart
Area of the Visual Acuity Curve (AoC) assessment3 months postoperativelyCalculation of the AoC as a visual outcome measure
Vision-Related Quality of Life3 months postoperativelythe degree of subjective satisfaction of the patient will be evaluated through an interview (NEI-VFQ 25)

Countries

Greece

Contacts

PRINCIPAL_INVESTIGATORGeorgios Labiris, Professor

University Hospital of Alexandroupolis, Alexandroupolis, Evros 68100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026